Sequel Med Tech
UnverifiedFacts from public sources. Is this your company? Claim your page.Medical technologyManchester, NHFounded 2023201–500 employees
The Lobby built this page from public sources. It isn’t maintained by or affiliated with Sequel Med Tech. Is this your company? Claim your page (free).
Overview
Sequel Med Tech, headquartered in Manchester, New Hampshire, is a medical device company developing drug-delivery technology, starting with diabetes. Its flagship product is the twiist Automated Insulin Delivery (AID) System for people with type 1 diabetes ages six and up, available by prescription only in the U.S., which Sequel made available nationwide in March 2026.
Hiring snapshot
Hiring by specialty
Open roles
Newest first, from Sequel Med Tech’s careers page.
Divisions
Division information is pending company verification.Once Sequel Med Tech claims its page, you will see each division, who it calls on and how it pays.
Claim your pageMore from Sequel Med Tech
These sections fill in when Sequel Med Tech claims and verifies its page.